Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Rating) CEO Ron Bentsur purchased 750 shares of the firm’s stock in a transaction that occurred on Monday, June 26th. The stock was bought at an average cost of $16.50 per share, for a total transaction of $12,375.00. Following the completion of the purchase, the chief executive officer now […]
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Rating) major shareholder Marlio Charles Mosseri purchased 6,091 shares of the stock in a transaction dated Wednesday, June 21st. The shares were acquired at an average price of $17.71 per share, with a total value of $107,871.61. Following the completion of the acquisition, the insider now owns 2,431,091 shares […]
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Rating) major shareholder Marlio Charles Mosseri acquired 6,091 shares of the stock in a transaction that occurred on Wednesday, June 21st. The stock was acquired at an average cost of $17.71 per share, with a total value of $107,871.61. Following the completion of the purchase, the insider now owns […]
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Rating) was down 1.6% on Tuesday . The company traded as low as $17.01 and last traded at $17.18. Approximately 65,192 shares traded hands during mid-day trading, an increase of 29% from the average daily volume of 50,708 shares. The stock had previously closed at $17.46. Analyst Ratings Changes […]